Surgery can be a challenging experience, not only for patients, but their clinicians and caregivers, as well. The lack of innovative medical devices with intelligent software following cardiothoracic surgery provided an opportunity for one MedTech company in particular.
Today’s guest is Evan Luxon, co-founder and CEO at Centese. The early stage company achieved 510(k) clearance from the FDA for its intelligent surgical drainage product called, Thoraguard. Centese followed a deliberate and diligent approach to design and development, while right-sizing its quality management system (QMS).
Listen to the full episode as this MedTech executive shares key insights, tips and best practices to help other MedTech leaders achieve similar success.
Like this episode? Subscribe today on iTunes or Spotify.
National Science Foundation (NSF)
Freedom of Information Act (FOIA)
Greenlight Guru True Quality Roadshow 2019
“Thoraguard is all about safety and minimizing risk for the patient.” Evan Luxon
“Surgical drainage is not a sexy topic. (Thoraguard) is an innovative device, but it’s not a robot.” Evan Luxon
“Control isn’t a bad word.” Jon Speer
“Build the quality system out as the project and company progress. Carve out exactly what’s needed at each phase of development.” Evan Luxon
MedTech True Quality Stories Podcast, powered by Greenlight Guru, takes listeners on a storytelling journey through personal narratives of MedTech executives who offer real-world, actionable advice to industry leaders for guidance towards future imagination, implementation, and innovation of True Quality medical devices.
Like this episode? Subscribe today on iTunes or SoundCloud.
Nick Tippmann is an experienced marketing professional lauded by colleagues, peers, and medical device professionals alike for his strategic contributions to Greenlight Guru from the time of the company’s inception. Previous to Greenlight Guru, he co-founded and led a media and event production company that was later...